biotech
Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
Filed in archive Biotech Hubs and Facilities , Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on March 22, 2007
Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
GlaxoSmithKline PLC had invested S$20 million (US$13 million; €9.8 million) in a new laboratory in Singapore's biotechnology hub, Biopolis, as part of its Center for Research in Cognitive and Neurodegenerative Disorders, which focuses on discovering drugs to help cure Alzheimer's disease and schizophrenia.
"This new investment in GSK's research and development facility will enhance our drug discovery capabilities in Singapore. Our goal is to identify a clinical development candidate by the end of 2007 and we are on track to achieving that," director Paul Chapman was quoted as saying in a statement.

The new laboratory opened Tuesday.

Source: International Herald Tribune

Permalink: Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
Tags: biotech  investment  biotech+investment  cognitive+disorder  alzheimer  schizophrenia  drug+discovery  drug 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/59223
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 4 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!